Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRiad Salem, Mary F. Mulcahy, Robert J. Lewandowski et al.|Gastroenterology|2010Cited by 649
Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival TimesKhairuddin Memon, Riad Salem, Laura Kulik et al.|Gastroenterology|2011Cited by 153
Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: Radiologic–pathologic correlationAhsun Riaz, Riad Salem, Khairuddin Memon et al.|Journal of Hepatology|2010Cited by 147
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysisKhairuddin Memon, Riad Salem, Laura Kulik et al.|Journal of Hepatology|2012Cited by 95
Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: Analyzing patterns of progression in 285 patientsSeanthan Senthilnathan, Riad Salem, Khairuddin Memon et al.|Hepatology|2011Cited by 75